GERMANTOWN, Md., April 25, 2019 /PRNewswire/ — Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and a clinical stage biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced the official opening of its new manufacturing facility. Precigen commenced the build-out of the nearly […]
The post Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland appeared first on SynBioBeta.